Finance

Lists
Why is NUVB down ၆.၃၂%?
Dive Deeper
NUVB:NYSE
Nuvation Bio Inc
၄.၄၅ US$
-၆.၃၂%
(-၀.၃၀) 1D
၄.၄၆ US$
+၀.၁၁% (+၀.၀၀၅၀)
After hours
Closed: အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၆  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
၄.၇၅ US$
High
၄.၇၆ US$
Low
၄.၄၂ US$
Mkt. cap
၁၅၆.၂၅ ဋေ
Avg. vol.
၅.၄၁ သန်း
Volume
၄.၄၇ သန်း
52-wk high
၉.၇၅ US$
52-wk low
၃.၃၆ US$
EPS
-၀.၄၄ US$
Beta
၁.၆၁
Shares outstanding
၃၅.၁၁ ကုဋေ
No. of employees
၃၀၅
Open
၄.၇၅ US$
High
၄.၇၆ US$
Low
၄.၄၂ US$
Mkt. cap
၁၅၆.၂၅ ဋေ
Avg. vol.
၅.၄၁ သန်း
Volume
၄.၄၇ သန်း
52-wk high
၉.၇၅ US$
52-wk low
၃.၃၆ US$
EPS
-၀.၄၄ US$
Beta
၁.၆၁
Shares outstanding
၃၅.၁၁ ကုဋေ
No. of employees
၃၀၅
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၂ ရက်
Top 3 Penny Stocks To Watch In October 2026
About Nuvation Bio Inc
CEODavid Hung
Employees၃၀၅
Founded၂၀၁၈
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current ၄.၄၅ US$
၂၁.၀၀ US$ (+၃၇၁.၉၁%)
Average
၁၄.၅၇ US$ (+၂၂၇.၄၂%)
Lowest
၁၁.၀၀ US$ (+၁၄၇.၁၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
၁၂.၀၀ US$
+၁၆၉.၇%
10/15/2026
Leonid Timashev
RBC Capital
Buy
Maintained
၂၀.၀၀ US$
+၃၄၉.၄%
10/12/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
၁၁.၀၀ US$
+၁၄၇.၂%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
၁၂.၀၀ US$
+၁၆၉.၇%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
၁၄.၀၀ US$
+၂၁၄.၆%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
၂၁.၀၀ US$
+၃၇၁.၉%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
၁၂.၀၀ US$
+၁၆၉.၇%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
၁၂.၀၀ US$
+၁၆၉.၇%
04/06/2026
Michael Yee
UBS
Hold
Maintained
၇.၀၀ US$
+၅၇.၃%
03/03/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
-၀.၁၅ US$ / -၀.၁၂ US$
-၂၅.၁၅%miss
Revenue / Est. (USD)
၃.၁၇ ကုဋေ / ၂.၈၇ ကုဋေ
+၁၀.၄၂%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁.၃၁ ကုဋေ
၄.၁၉ ကုဋေ
၈.၃၂ ကုဋေ
၃.၁၇ ကုဋေ
Cost of goods sold
၃.၃၅ သန်း
၁.၂၈ သန်း
၅.၉၉ သန်း
၉.၄၇ သန်း
Cost of revenue
၃.၃၅ သန်း
၁.၂၈ သန်း
၅.၉၉ သန်း
၉.၄၇ သန်း
Research and development expenses
၂.၈၈ ကုဋေ
၃.၄၃ ကုဋေ
၃.၅၀ ကုဋေ
၃.၀၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၇၄ ကုဋေ
၄.၀၃ ကုဋေ
၃.၈၃ ကုဋေ
၄.၂၆ ကုဋေ
Operating expense
၆.၆၂ ကုဋေ
၇.၄၆ ကုဋေ
၇.၃၄ ကုဋေ
၇.၃၃ ကုဋေ
Total operating expenses
၆.၉၆ ကုဋေ
၇.၅၉ ကုဋေ
၇.၉၃ ကုဋေ
၈.၂၇ ကုဋေ
Operating income
-၅.၆၄ ကုဋေ
-၃.၄၀ ကုဋေ
၃.၈၈ သန်း
-၅.၁၀ ကုဋေ
Other non operating income
၁.၁၄ သန်း
-၁.၁၈ သန်း
၃.၁၁ သန်း
-၁.၇၉ သိန်း
EBT including unusual items
-၅.၅၈ ကုဋေ
-၃.၆၆ ကုဋေ
၅.၄၀ သန်း
-၆.၂၈ ကုဋေ
EBT excluding unusual items
-၅.၅၈ ကုဋေ
-၃.၆၆ ကုဋေ
၅.၃၉ သန်း
-၅.၃၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၅.၅၈ ကုဋေ
-၃.၆၆ ကုဋေ
၅.၄၀ သန်း
-၆.၂၈ ကုဋေ
Net profit margin
-၄၂၅.၂၄%
-၈၇.၄၀%
၆.၄၈%
-၁၉၈.၃၁%
Earnings per share
-၀.၁၄
-၀.၀၉
၀.၀၄
-၀.၁၅
Interest and investment income
၆.၀၃ သန်း
၅.၃၀ သန်း
၅.၁၁ သန်း
၄.၆၀ သန်း
Interest expense
-၆.၅၃ သန်း
-၆.၆၇ သန်း
-၆.၇၁ သန်း
-၆.၇၆ သန်း
Net interest expenses
-၅.၀၁ သိန်း
-၁.၃၈ သန်း
-၁.၆၀ သန်း
-၂.၁၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၅၉ ကုဋေ
-၃.၃၅ ကုဋေ
၄.၄၂ သန်း
-၅.၀၅ ကုဋေ
Gain or loss from assets sale
-၄.၀၀ ထောင်
၃.၀၀ ထောင်
-
-၁.၀၀ ထောင်
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ